Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

التفاصيل البيبلوغرافية
العنوان: Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
المؤلفون: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
المصدر: Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability
Liu S, Hu C, Peters J, Tsang A, Cremers S, Bies R, Page-Wilson G. Pharmacokinetics and pharmacodynamics of ropinirole in patients with prolactinomas. Br J Clin Pharmacol. 2019 Feb;85(2):366-376. doi: 10.1111/bcp.13802. Epub 2018 Nov 22.
قاعدة البيانات: ClinicalTrials.gov